-transparent.png){kind=logo}
OBJECTIVE This study examined the relation between left atrial spontaneous echo contrast, hematologic variables and thrombo-embolism in patients with nonvalvular atrial fibrillation. BACKGROUND Left atrial spontaneous echo contrast is associated with left atrial stasis and thromboembolism in patients with nonvalvular atrial fibrillation. However, its hematologic determinants in patients with nonvalvular atrial fibrillation are unknown. METHODS Clinical, hematologic and echocardiographic variables were prospectively measured in 135 consecutive patients with nonvalvular atrial fibrillation undergoing transesophageal echocardiography. RESULTS Patients with left atrial spontaneous echo contrast (n = 74, 55%) had an increased fibrinogen concentration (p = 0.029), platelet count (p = 0.045), hematocrit (p = NS) and left atrial dimension (p = 0.005). Multivariate analysis showed that left atrial spontaneous echo contrast was independently related to hematocrit (odds ratio = 2.24, p = 0.002), fibrinogen concentration (odds ratio = 2.08, p = 0.008) and left atrial dimension (odds ratio = 1.90, p = 0.004) but not platelet count. It was also associated with left atrial thrombus (n = 15, p = 0.001) and with recent embolism (n = 40, p < 0.001). In 40 clinically stable outpatients without previous embolism, left atrial spontaneous echo contrast was significantly related to hematocrit (p = 0.005), fibrinogen concentration (p = 0.035) and left atrial dimension (p = 0.029) but not to coagulation factor VII, D-dimer, erythrocyte sedimentation rate, platelet count, plasma beta-thromboglobulin, plasma glycocalicin or glycocalicin index. CONCLUSIONS Left atrial spontaneous echo contrast in patients with nonvalvular atrial fibrillation is independently related to hematocrit, fibrinogen concentration and left atrial dimension, indicating a relatively hypercoagulable state in addition to stasis. These findings support the hypothesis that left atrial spontaneous echo contrast is due to erythrocyte aggregation. Hematologic factors may contribute to its association with thromboembolism.
I W Black, and
C N Chesterman, and
A P Hopkins, and
L C Lee, and
B H Chong, and
W F Walsh
September 1994,
Journal of the American College of Cardiology,
I W Black, and
C N Chesterman, and
A P Hopkins, and
L C Lee, and
B H Chong, and
W F Walsh
November 2020,
Thrombosis research,
I W Black, and
C N Chesterman, and
A P Hopkins, and
L C Lee, and
B H Chong, and
W F Walsh
October 1999,
The American journal of cardiology,
I W Black, and
C N Chesterman, and
A P Hopkins, and
L C Lee, and
B H Chong, and
W F Walsh
January 1994,
Cardiology,
I W Black, and
C N Chesterman, and
A P Hopkins, and
L C Lee, and
B H Chong, and
W F Walsh
June 2022,
Polish archives of internal medicine,
I W Black, and
C N Chesterman, and
A P Hopkins, and
L C Lee, and
B H Chong, and
W F Walsh
September 2022,
Journal of cardiovascular development and disease,
I W Black, and
C N Chesterman, and
A P Hopkins, and
L C Lee, and
B H Chong, and
W F Walsh
May 2023,
Thrombosis and haemostasis,
I W Black, and
C N Chesterman, and
A P Hopkins, and
L C Lee, and
B H Chong, and
W F Walsh
April 1994,
The American journal of cardiology,
I W Black, and
C N Chesterman, and
A P Hopkins, and
L C Lee, and
B H Chong, and
W F Walsh
January 1999,
Heart and vessels,
I W Black, and
C N Chesterman, and
A P Hopkins, and
L C Lee, and
B H Chong, and
W F Walsh
January 2024,
Echocardiography (Mount Kisco, N.Y.),
